Accelerating Your Formulations

Accelerating Your Formulations

In today’s fast-paced world of pharmaceutical and consumer products commercialization, first to market with proven technology is often the key to better outcomes. Purisys offers a range of pre-formulation solutions to minimize the time it takes to launch a product.

Purisys R&D scientists draw from expertise in cannabinoids and particle engineering to provide robust pre-formulation solutions, which are detailed in comprehensive technical reports. Our partnerships with industry-leading excipient suppliers enable pre-formulation options to be developed and delivered to effectively support finished dosage form and delivery system development.

Additional solutions include characterization studies that help to resolve stability and bioavailability problems. Purisys has a broad suite of analytical tools, technology, and expertise to troubleshoot developmental and commercial problems.

Purisys, in addition, helps to accelerate your dosage development by providing detailed technical reports that outline specific cannabinoid and excipient compatibilities and by working in conjunction with excipient suppliers to deliver efficient pre-formulation options. Our R&D and Regulatory Affairs teams also enable you to advance these solutions within tight timeframes.

Solutions Purisys now supports include:

  • Pre-formulation solutions for cannabinoids
  • Advanced predictive API & ingredient stability studies
  • Bioavailability enhancement solutions
  • Compatibility studies with select excipients
  • Particle sizing and characterization studies
  • Formulation and analytical associated technologies
  • World-class technical information and knowledge regarding impurities

Ask us for any information you may require to use our cannabinoids in your finished dose and solve formulation challenges or bring us a new problem to solve.